If you are not able to view this e-mail properly, please click here to view it online
World Pharma Today Maqazine
World Pharma Today Linkedin Page World Pharma Today Facebook Page World Pharma Today Twitter Page Weekly Newsletter
Click here to subscribe to our Magazine
PharmaLytica
Top Latest Press Releases
Videojet launches new, faster 3640 CO2 laser marking system

Videojet launches new, faster 3640 CO2 laser marking system to meet manufacturers speed demands

Manufacturers with high volume and high speed production lines rely on their coding and marking system availability to keep production lines running.nplanned downtime can lead to considerable production loss and high-speed...

READ MORE

goBalto and Informa Partner to Accelerate Site Selection for Global Clinical Trials

goBalto, Inc., the leading provider of cloud-based clinical study startup solutions, announced its partnership with Citeline, part of Informa Pharma Intelligence vertical, to integrate data...

READ MORE

Lannett Receives Approval For Niacin Extended-Release Tablets USP, 500 Mg And 1000 Mg

Lannett Company Inc announced that it received approval from the U.S. FDA of its Abbreviated New Drug Application for Niacin Extended-Release Tablets USP, 500 mg and 1000 mg...

READ MORE
Articles
New Single Quadrupole Mass Spectrometer Designed to Deliver Reproducible and Robust Separation

New Single Quadrupole Mass Spectrometer Designed to Deliver Reproducible and Robust Separations, Increase Analytical Accuracy

Thermo Fisher Scientific Inc., the world leader in serving science, announced new technologies that are designed to allow analytical chemists to obtain high-resolution separations with outstanding sensitivity and reproducibility.

READ MORE

QuVa Announces Availability of Sodium Bicarbonate Syring

Compounded Sodium Bicarbonate PF 8.4 percentage of 50mEq per syringe is expected to help alleviate chronic drug shortage impacting the nation hospitals. A shortage of the antacid is prompting healthcare providers to carefully...

READ MORE

Sandoz receives approval in Europe for Rixatho to treat blood cancers and immunological diseases

Sandoz, a Novartis division, and the pioneer and global leader in biosimilars, announced that the EC has approved Rixatho for use in Europe . Rixathon is approved for use in all indications...

READ MORE
 

For Advertising Queries:

Please e-mail : kathryn@worldpharmatoday.com
or
call to: + 91 88268 49084

If you like to receive our latest Media Pack 2017 / Editorial Calender please click here

 

For the latest visit: www.worldpharmatoday.com

World Pharma Today